Email This News Release


"Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome"

Your privacy is important to us. We will never share your email or other information with a third party.